Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open … C Zhou, YL Wu, G Chen, J Feng, XQ Liu, C Wang, S Zhang, J Wang, ... The lancet oncology 12 (8), 735-742, 2011 | 3862 | 2011 |
Passive and active droplet generation with microfluidics: a review P Zhu, L Wang Lab on a Chip 17 (1), 34-75, 2017 | 425 | 2017 |
Recent advances of cocktail chemotherapy by combination drug delivery systems Q Hu, W Sun, C Wang, Z Gu Advanced drug delivery reviews 98, 19-34, 2016 | 341 | 2016 |
Review of heat conduction in nanofluids J Fan, L Wang Journal of heat transfer 133 (4), 2011 | 330 | 2011 |
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell … C Zhou, YL Wu, G Chen, J Feng, XQ Liu, C Wang, S Zhang, J Wang, ... Annals of Oncology 26 (9), 1877-1883, 2015 | 292 | 2015 |
Light‐Activated Hypoxia‐Responsive Nanocarriers for Enhanced Anticancer Therapy C Qian, J Yu, Y Chen, Q Hu, X Xiao, W Sun, C Wang, P Feng, QD Shen, ... Advanced materials 28 (17), 3313-3320, 2016 | 290 | 2016 |
Rationally designed 1D Ag@ AgVO 3 nanowire/graphene/protonated gC 3 N 4 nanosheet heterojunctions for enhanced photocatalysis via electrostatic self-assembly and photochemical … S Zhang, J Li, X Wang, Y Huang, M Zeng, J Xu Journal of Materials Chemistry A 3 (18), 10119-10126, 2015 | 290* | 2015 |
Induction of apoptosis by hibiscus protocatechuic acid in human leukemia cells via reduction of retinoblastoma (RB) phosphorylation and Bcl-2 expression TH Tseng, TW Kao, CY Chu, FP Chou, WL Lin, CJ Wang Biochemical Pharmacology 60 (3), 307-315, 2000 | 263 | 2000 |
Heat conduction: mathematical models and analytical solutions L Wang, X Zhou, X Wei Springer Science & Business Media, 2007 | 249 | 2007 |
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study WZ Zhong, Q Wang, WM Mao, ST Xu, L Wu, Y Shen, YY Liu, C Chen, ... The Lancet Oncology 19 (1), 139-148, 2018 | 220 | 2018 |
Inhibitory effect of Hibiscus protocatechuic acid on tumor promotion in mouse skin TH Tseng, JD Hsu, MH Lo, CY Chu, FP Chou, CL Huang, CJ Wang Cancer Letters 126 (2), 199-207, 1998 | 214 | 1998 |
Catalytic oxidation of vinyl chloride emission over LaMnO3 and LaB0. 2Mn0. 8O3 (B= Co, Ni, Fe) catalysts C Zhang, C Wang, W Zhan, Y Guo, Y Guo, G Lu, A Baylet, ... Applied Catalysis B: Environmental 129, 509-516, 2013 | 200 | 2013 |
Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery H Li, C Wang, J Yu, S Cao, F Wei, W Zhang, Y Han, X Ren Cytotherapy 11 (8), 1076-1083, 2009 | 192 | 2009 |
MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN B Liu, X Wu, B Liu, C Wang, Y Liu, Q Zhou, K Xu Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1822 (11 …, 2012 | 183 | 2012 |
Stability of dynamical systems X Liao, LQ Wang, P Yu Elsevier, 2007 | 171 | 2007 |
Critical issues in nanofluids preparation, characterization and thermal conductivity D Wu, H Zhu, L Wang, L Liu Current Nanoscience 5 (1), 103-112, 2009 | 159 | 2009 |
Nanofluids S Choi, Y Jaluria, O Manca, L Wang | 150 | 2011 |
The electronic stethoscope S Leng, R San Tan, KTC Chai, C Wang, D Ghista, L Zhong Biomedical engineering online 14 (1), 1-37, 2015 | 143 | 2015 |
Nanofluids research: key issues L Wang, J Fan Nanoscale Research Letters 5 (8), 1241-1252, 2010 | 143 | 2010 |
Fabrication and characterization of monodisperse PLGA–alginate core–shell microspheres with monodisperse size and homogeneous shells for controlled drug release J Wu, T Kong, KWK Yeung, HC Shum, KMC Cheung, L Wang, MKT To Acta biomaterialia 9 (7), 7410-7419, 2013 | 132 | 2013 |